Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M67,399Revenue $M21,848Net Margin (%)10.8Z-Score0
Enterprise Value $M67,399EPS $1.6Operating Margin %13.0F-Score0
P/E(ttm))30.1Cash Flow Per Share $6.7Pre-tax Margin (%)12.6Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %-5.5Quick Ratio0Cash flow > EarningsN
Price/Sales3.25-y EBITDA Growth Rate %-23.9Current Ratio0Lower Leverage y-yN
Price/Cash Flow9.8y-y EBITDA Growth Rate %-23.9ROA % (ttm)6.4Higher Current Ratio y-yN
Dividend Yield %2.0Insider Buy (3m)0ROE % (ttm)11.5Less Shares Outstanding y-yN
Payout Ratio %63.0Shares Outstanding M1,506ROI % (ttm)9.7Gross Margin Increase y-yN

Gurus Latest Trades with ABT

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTKen Fisher 2014-12-31 Add$39.99 - $46.37
($43.58)
$ 44.763%Add 22.8%13,828
ABTKen Fisher 2014-09-30 Reduce$41.05 - $43.69
($42.33)
$ 44.766%Reduce -37.53%11,261
ABTMason Hawkins 2014-09-30 Reduce-0.26%$41.05 - $43.69
($42.33)
$ 44.766%Reduce -8.8%12,483,566
ABTMario Gabelli 2014-09-30 Reduce-0.01%$41.05 - $43.69
($42.33)
$ 44.766%Reduce -38.44%98,937
ABTRay Dalio 2014-09-30 Sold Out -0.01%$41.05 - $43.69
($42.33)
$ 44.766%Sold Out0
ABTJean-Marie Eveillard 2014-06-30 Buy 0.16%$37.02 - $41
($39.24)
$ 44.7614%New holding, 1665688 sh.1,665,688
ABTKen Fisher 2014-06-30 Add$37.02 - $41
($39.24)
$ 44.7614%Add 106.12%18,027
ABTGeorge Soros 2014-06-30 Reduce-0.11%$37.02 - $41
($39.24)
$ 44.7614%Reduce -23.73%932,181
ABTRichard Pzena 2014-03-31 Add0.11%$35.85 - $40.12
($38.5)
$ 44.7616%Add 7.9%6,934,282
ABTGeorge Soros 2014-03-31 Add0.1%$35.85 - $40.12
($38.54)
$ 44.7616%Add 25.97%1,222,181
ABTRay Dalio 2014-03-31 Buy 0.01%$35.85 - $40.12
($38.54)
$ 44.7616%New holding, 17200 sh.17,200
ABTDaniel Loeb 2014-03-31 Sold Out -2.1%$35.85 - $40.12
($38.54)
$ 44.7616%Sold Out0
ABTDaniel Loeb 2013-12-31 Buy 2.1%$33.01 - $38.71
($36.89)
$ 44.7621%New holding, 3250000 sh.3,250,000
ABTRobert Olstein 2013-12-31 Add0.19%$33.01 - $38.71
($36.89)
$ 44.7621%Add 23.45%179,000
ABTMario Gabelli 2013-12-31 Add0.02%$33.01 - $38.71
($36.89)
$ 44.7621%Add 110.21%197,183
ABTRay Dalio 2013-12-31 Sold Out -0.03%$33.01 - $38.71
($36.89)
$ 44.7621%Sold Out0
ABTRichard Pzena 2013-09-30 Add0.46%$32.93 - $36.88
($35.12)
$ 44.7627%Add 49.22%6,449,283
ABTPRIMECAP Management 2013-09-30 Add0.19%$32.93 - $36.88
($35.12)
$ 44.7627%Add 36.9%16,188,865
ABTRay Dalio 2013-09-30 Buy 0.03%$32.93 - $36.88
($35.12)
$ 44.7627%New holding, 118700 sh.118,700
ABTKen Fisher 2013-09-30 Reduce$32.93 - $36.88
($35.12)
$ 44.7627%Reduce -21.02%8,439
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ABT Ken Fisher 2014-12-3113,82800+22.8%
ABT Dodge & Cox 2014-09-3039,62800+7.4%
ABT Richard Pzena 2014-09-307,287,5230.481.7+1.25%
ABT Robert Olstein 2014-09-30182,0000.010.99
ABT Robert Bruce 2014-09-30229,3000.022.6
ABT Vanguard Health Care Fund 2014-09-307,591,4000.50.81
ABT PRIMECAP Management 2014-09-3017,089,2571.130.76-0.22%
ABT Mason Hawkins 2014-09-3012,483,5660.832.8-8.8%
ABT Jean-Marie Eveillard 2014-09-301,426,9190.090.15-14.33%
ABT George Soros 2014-09-30797,1810.050.25-14.48%
ABT Ken Fisher 2014-09-3011,26100-37.53%
ABT Mario Gabelli 2014-09-3098,9370.010.02-38.44%
ABT Ray Dalio 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Contreras JaimeSenior Vice President 2014-11-25Sell51,600$44.072.7view
Contreras JaimeSenior Vice President 2014-11-10Sell6,300$43.683.62view
WHITE MILES DChairman and CEO 2014-10-29Sell440,800$42.526.44view
Ford Robert BSenior Vice President 2014-07-01Sell0$06.44view
Foltz Charles DSenior Vice President 2014-03-03Sell1,588$38.9516.2view
Landgraf John CExecutive Vice President 2014-03-03Sell17,293$39.3814.93view
Doyle Katherine C.Senior Vice President 2014-03-03Sell6,639$39.0116.02view
Warmuth Michael JExecutive Vice President 2014-03-03Sell16,484$39.0116.02view
Contreras JaimeSenior Vice President 2014-03-03Sell8,081$39.3714.96view
Mason Heather LSenior Vice President 2014-03-03Sell2,196$38.9516.2view

Press Releases about ABT :

    Quarterly/Annual Reports about ABT:

    News about ABT:

    Articles On GuruFocus.com
    What Could Be The Major Highlights In AbbVie’s Upcoming Earnings Call? Jan 29 2015 
    Feeling Good With This Med Company Jan 20 2015 
    Diamond Hill Adds Two Companies to Portfolio in Third Quarter Dec 11 2014 
    Boston Scientific Lost the First Place in Innovation Dec 11 2014 
    Top 7 Dividend Aristocrats: The Best of The Best Dec 10 2014 
    6 Stocks Giving Investors Potential Dividend Hikes In December Dec 04 2014 
    Dividend Aristocrats In Focus Part 45: AbbVie Nov 24 2014 
    Dividend Aristocrats In Focus Part 41: Abbott Laboratories (ABT) Nov 17 2014 
    Sure Bets: Slow-Changing Industries for Long-Term Investors Oct 01 2014 
    Market Indicators That Could Spell Trouble for Investors Sep 29 2014 


    More From Other Websites
    Thursday's Market Recap Jan 29 2015
    At Least One CEO Isn't Going to Use Currencies as an Excuse Jan 29 2015
    Abbott CEO losing no sleep over stronger dollar Jan 29 2015
    Thermo Fisher, Varian, Abbott Up On Earnings Reports Jan 29 2015
    Abbott Laboratories (ABT) Earnings Report: Q4 2014 Conference Call Transcript Jan 29 2015
    Mylan says shareholders approve Abbott business purchase Jan 29 2015
    Mylan says shareholders approve Abbott business purchase Jan 29 2015
    Abbott Labs' (ABT) Q4 Earnings Up, Guides Below Estimates - Analyst Blog Jan 29 2015
    Mylan Shareholders Overwhelmingly Approve Agreement Implementing Acquisition of Abbott's Non-U.S.... Jan 29 2015
    Mylan Shareholders Overwhelmingly Approve Agreement Implementing Acquisition of Abbott's Non-U.S.... Jan 29 2015
    Abbott Labs 2015 outlook largely in line with estimates Jan 29 2015
    Abbott Labs (ABT) Earnings up Y/Y, Stent Sales Decline - Tale of the Tape Jan 29 2015
    Abbott Laboratories Earnings Call scheduled for 9:00 am ET today Jan 29 2015
    ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jan 29 2015
    Abbott Laboratories Profit Grows 54% Jan 29 2015
    Abbott beats 4Q profit forecasts Jan 29 2015
    Abbott beats 4Q profit forecasts Jan 29 2015
    Abbott Labs posts sales decline in nutrition business Jan 29 2015
    Abbott Labs profit beats Street estimates Jan 29 2015
    7:50 am Abbott Labs beats by $0.03, misses on revs; guides Q1 EPS in-line; guides FY15 EPS below... Jan 29 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK